Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human CD276 Recombinant Antibody(Enoblituzumab)

Product Information
Catalog Number YR1399
Product Name Anti-Human CD276 Recombinant Antibody(Enoblituzumab)
Molecular Name Enoblituzumab
Alias Anti-CD276 Recombinant Antibody, Research Grade Enoblituzumab
CAS Number 1353485-38-7
Target CD276[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications ELISA, IHC, IF, IP, FCM, FuncS
Buffer PBS, pH7.5
Background Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators. This drug was developed by MacroGenics, Inc.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.